FIELD: medicine.
SUBSTANCE: invention relates to virology. Vaccinal composition for treatment and prevention of hepatitis C contains as components structure proteins of hepatitis C virus in certain ratio. Composition has reinforcing effect on development of immune response against hepatitis C virus. Also described are combined vaccines against pathogenic organisms, which include said vaccinal composition.
EFFECT: invention can be used in medicine.
10 cl, 64 dwg, 5 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
| CHEMERICAL ANTIGENES FOR VACCINE AGAINST HEPATITIS C VIRUS | 2013 |
|
RU2639504C2 |
| PHARMACEUTICAL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2004 |
|
RU2362586C2 |
| METHOD FOR PRODUCTION OF ANTIGEN AGGREGATES AND USES THEREOF IN PHARMACEUTICALS | 2001 |
|
RU2266754C2 |
| OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS | 1999 |
|
RU2247729C2 |
| RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS | 2002 |
|
RU2270860C2 |
| APPLICATION OF PACAP AS MOLECULAR ADJUVANT FOR VACCINES | 2012 |
|
RU2580294C2 |
| SUPPOSITORY FOR IMMUNOPROPHYLAXIS OF VIRAL INFECTIONS | 2004 |
|
RU2296560C2 |
| CHIMERIC VACCINE ANTIGENS AGAINST CLASSICAL SWINE PLAGUE VIRUS | 2007 |
|
RU2406534C2 |
| UNIVERSAL ANTI-INFECTIOUS VACCINE | 2015 |
|
RU2618918C2 |
